Last update 08 Aug 2026

VMD-102

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
VMD 102, VMD102, VMD-102
Target
PKCε
Action
inhibitors
Mechanism
PKCε inhibitors(protein kinase C epsilon inhibitors)
Therapeutic Areas
NeoplasmsDigestive System DisordersEye Diseases+ [4]
Active Indication
Advanced Malignant Solid NeoplasmColorectal CancerNon-Small Cell Lung Cancer+ [3]
Inactive Indication-
Originator Organization
VM Discovery, Inc.VM Discovery, Inc.
Active Organization
VM Discovery, Inc.VM Discovery, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with VMD-102
NCT07636785
/ Not yet recruitingPhase 1/2
A Phase 1 and 2 First-in-human, Open-label, Multicenter Study to Assess the Safety, Tolerability and Preliminary Efficacy of VMD-102 in Participants With Hepatocellular Carcinoma and Other Advanced Solid Tumors
100 Clinical Results associated with VMD-102
Login to view more data
100 Translational Medicine associated with VMD-102
Login to view more data
100 Patents (Medical) associated with VMD-102
Login to view more data
100 Deals associated with VMD-102
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 2
United States
VM Discovery, Inc.VM Discovery, Inc.
01 Jun 2026
Colorectal CancerPhase 2
United States
VM Discovery, Inc.VM Discovery, Inc.
01 Jun 2026
Non-Small Cell Lung CancerPhase 2
United States
VM Discovery, Inc.VM Discovery, Inc.
01 Jun 2026
Renal Cell CarcinomaPhase 2
United States
VM Discovery, Inc.VM Discovery, Inc.
01 Jun 2026
Unresectable Hepatocellular CarcinomaPhase 2
United States
VM Discovery, Inc.VM Discovery, Inc.
01 Jun 2026
Uveal MelanomaPhase 2
United States
VM Discovery, Inc.VM Discovery, Inc.
01 Jun 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free